Drug Type Synthetic peptide |
Synonyms XEN 2174 |
Target |
Action inhibitors |
Mechanism NET inhibitors(Norepinephrine transporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC58H85N17O16S4 |
InChIKeyFABZJQVOEXQFRZ-LRIIMAMNSA-N |
CAS Registry701909-57-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cancer Pain | Phase 2 | United States | - | |
Cancer Pain | Phase 2 | Australia | - | |
Chronic Pain | Phase 2 | - | - | |
Pain, Postoperative | Phase 2 | United States | - | |
Pain, Postoperative | Phase 2 | Bulgaria | - | |
Hypersensitivity | Preclinical | United States | 27 Oct 2004 |